Deferoxamine for the Treatment of Hemochromatosis

NCT00001203 · clinicaltrials.gov ↗

COMPLETED

Status

151

Enrollment

NIH

Sponsor class

Conditions

Diabetes Mellitus
Heart Disease
Hemochromatosis
Thalassemia

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)